Regeneus Ltd. (AU:CMB) has released an update.
Cambium Bio Limited has announced a new issuance of 426,975,472 ordinary fully paid securities set to be quoted on the ASX under the code CMB, with the issue date slated for June 28, 2024. This move indicates a significant event for the company and its investors, signaling potential growth and a broadening of the shareholder base.
For further insights into AU:CMB stock, check out TipRanks’ Stock Analysis page.
